Citadel Advisors’s Cocrystal Pharma COCP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-10,034
| Closed | -$14.2K | – | 5976 |
|
|
2025
Q1 | $14.2K | Buy |
+10,034
| New | +$14.2K | ﹤0.01% | 5655 |
|
|
2022
Q4 | – | Sell |
-6,660
| Closed | -$23K | – | 6128 |
|
|
2022
Q3 | $23K | Buy |
+6,660
| New | +$23K | ﹤0.01% | 5506 |
|
|
2021
Q4 | – | Sell |
-9,028
| Closed | -$114K | – | 6530 |
|
|
2021
Q3 | $114K | Sell |
9,028
-117
| -1% | -$1.48K | ﹤0.01% | 5776 |
|
|
2021
Q2 | $137K | Buy |
+9,145
| New | +$137K | ﹤0.01% | 5798 |
|
|
2020
Q2 | – | Sell |
-2,406
| Closed | -$21K | – | 4704 |
|
|
2020
Q1 | $21K | Sell |
2,406
-544
| -18% | -$4.75K | ﹤0.01% | 4655 |
|
|
2019
Q4 | $18K | Buy |
+2,950
| New | +$18K | ﹤0.01% | 4519 |
|
|
2019
Q3 | – | Sell |
-1,264
| Closed | -$36K | – | 4716 |
|
|
2019
Q2 | $36K | Buy |
1,264
+30
| +2% | +$854 | ﹤0.01% | 4410 |
|
|
2019
Q1 | $40K | Buy |
+1,234
| New | +$40K | ﹤0.01% | 4286 |
|